Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor

Journal of General Virology

Volumn 83, Issue 1, 2002, Pages 151-155

  Cohen, C J ^a   Xiang, Z Q ^a   Gao, G P ^a   Ertl, H C J ^a   Wilson, J M ^a   Bergelson, J M ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIBODY; VIRUS RECEPTOR; VIRUS VECTOR;

ADAPTATION; ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CHIMPANZEE; CHO CELL; CONTROLLED STUDY; COXSACKIE VIRUS; GENE DELIVERY SYSTEM; GENE INTERACTION; GENETIC TRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; SOLUBILITY; VIROGENESIS; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS TYPING;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS; DNA VIRUSES; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 5; MURINAE; PAN TROGLODYTES; RNA VIRUSES;

EID: 0036135046     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-1-151     Document Type: Article

References (26)

1. Adenovirus type 37 uses sialic acid as a cellular receptor
2. Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants
3. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
4. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR
5. A replication defective vector based on a chimpanzee adenovirus
6. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts
7. Adenovirus type 5 fiber knob binds to MHC class 1 α2 domain at the surface of human epithelial and B lymphoblastoid cells
8. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells
9. Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy
10. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer
11. Coxsackie and adenovirus receptor (CAR)-dependent and major histocompatibility complex (MHC) class I-independent uptake of recombinant adenoviruses into human tumour cells
12. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus
13. Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle
14. Comparative analysis of adenovirus fiber-cell interaction: Adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment
15. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F
16. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae
17. Expression of a human coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes
18. Dependence of adenovirus infectivity on length of the fiber shaft domain
19. Canine adenovirus type 2 attachment and internalization: Coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway
20. Defining CAR as a cellular receptor for the avian adenovirus CELO using a genetic analysis of the two viral fibre proteins
21. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
22. In vitro adenoviral vector p53- mediated transduction and killing correlates with expression of coxsackievirus-adenovirus receptor and αVβ5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma
23. Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells
24. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection
25. Integrins αVβ3 and αVβ5 promote adenovirus internalization but not virus attachment
26. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant